Omega Healthcare Investors, Inc. $OHI Stock Sold by Sumitomo Mitsui Trust Group Inc.

Sumitomo Mitsui Trust Group Inc. lowered its holdings in shares of Omega Healthcare Investors, Inc. (NYSE:OHI) by 8.4% during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 296,667 shares of the real estate investment trust’s stock after selling 27,113 shares during the period. Sumitomo Mitsui Trust Group Inc. owned about 0.10% of Omega Healthcare Investors worth $13,739,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also recently bought and sold shares of OHI. BlackRock Inc. acquired a new position in shares of Omega Healthcare Investors in the 2nd quarter valued at $1,838,155,000. Bank of New York Mellon Corp acquired a new stake in shares of Omega Healthcare Investors during the 2nd quarter valued at about $275,230,000. Dimensional Fund Advisors LP boosted its position in shares of Omega Healthcare Investors by 2.5% during the 1st quarter. Dimensional Fund Advisors LP now owns 4,423,120 shares of the real estate investment trust’s stock valued at $193,824,000 after acquiring an additional 108,736 shares in the last quarter. Bank of America Corp DE boosted its position in shares of Omega Healthcare Investors by 3.6% during the 1st quarter. Bank of America Corp DE now owns 3,794,730 shares of the real estate investment trust’s stock valued at $166,285,000 after acquiring an additional 131,000 shares in the last quarter. Finally, Quantinno Capital Management LP increased its stake in Omega Healthcare Investors by 48.5% in the first quarter. Quantinno Capital Management LP now owns 2,125,931 shares of the real estate investment trust’s stock valued at $93,158,000 after acquiring an additional 694,426 shares during the period. Institutional investors own 65.25% of the company’s stock.

Omega Healthcare Investors Stock Down 2.3%

Shares of NYSE OHI opened at $48.04 on Friday. The stock has a market cap of $14.56 billion, a PE ratio of 15.04, a PEG ratio of 1.99 and a beta of 0.56. The business has a fifty day moving average of $46.25 and a two-hundred day moving average of $46.67. Omega Healthcare Investors, Inc. has a 52-week low of $41.53 and a 52-week high of $52.39. The company has a debt-to-equity ratio of 0.70, a quick ratio of 6.03 and a current ratio of 6.22.

Omega Healthcare Investors (NYSE:OHI) last posted its earnings results on Tuesday, November 3rd. The real estate investment trust reported $0.27 earnings per share for the quarter, missing the consensus estimate of $0.47 by ($0.20). Omega Healthcare Investors had a return on equity of 13.66% and a net margin of 58.11%. The firm had revenue of $340.55 million during the quarter, compared to the consensus estimate of $269.16 million. During the same period in the previous year, the company posted $0.79 EPS. The firm’s revenue for the quarter was down 3.0% compared to the same quarter last year. As a group, equities research analysts expect that Omega Healthcare Investors, Inc. will post 3.12 earnings per share for the current fiscal year.

Omega Healthcare Investors Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Monday, November 16th. Stockholders of record on Thursday, November 5th will be issued a dividend of $0.68 per share. The ex-dividend date of this dividend is Thursday, November 5th. This represents a $2.72 annualized dividend and a dividend yield of 5.7%. Omega Healthcare Investors’s dividend payout ratio (DPR) is presently 97.14%.

Analyst Upgrades and Downgrades

OHI has been the subject of several recent research reports. Mizuho increased their price target on shares of Omega Healthcare Investors from $45.00 to $46.00 and gave the stock a “neutral” rating in a research report on Monday, August 31st. UBS Group cut their price target on shares of Omega Healthcare Investors from $54.00 to $52.00 and set a “buy” rating for the company in a research note on Tuesday, October 13th. Citigroup raised Omega Healthcare Investors from a “buy” rating to an “outperform” rating in a report on Thursday, October 22nd. Wells Fargo & Company lowered their price objective on Omega Healthcare Investors from $48.00 to $46.00 and set an “equal weight” rating on the stock in a research note on Monday, October 19th. Finally, Citizens Jmp raised Omega Healthcare Investors from a “market perform” rating to a “market outperform” rating and set a $52.00 target price for the company in a report on Thursday, October 22nd. Seven analysts have rated the stock with a Buy rating, seven have given a Hold rating and two have issued a Sell rating to the company’s stock. Based on data from MarketBeat, the stock has a consensus rating of “Hold” and an average target price of $49.93.

Omega Healthcare Investors Company Profile

Omega Healthcare Investors, Inc is a real estate investment trust focused on the healthcare sector. The company invests in and owns healthcare facilities, with a primary emphasis on skilled nursing and assisted living properties.

Omega generally leases its properties to healthcare operators under long-term agreements, supporting services for seniors and individuals who require post-acute, rehabilitative, or long-term care. Its portfolio has also included other healthcare-related properties, such as continuing care retirement communities and specialty facilities.

Founded in 1992 and headquartered in Hunt Valley, Maryland, Omega serves healthcare operators across the United States and the United Kingdom.